Found: 13
Select item for more details and to access through your institution.
Radiolabeling Strategies of Nanobodies for Imaging Applications.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 9, p. 1530, doi. 10.3390/diagnostics11091530
- By:
- Publication type:
- Article
DOTA-ZOL: A Promising Tool in Diagnosis and Palliative Therapy of Bone Metastasis—Challenges and Critical Points in Implementation into Clinical Routine.
- Published in:
- Molecules, 2020, v. 25, n. 13, p. 2988, doi. 10.3390/molecules25132988
- By:
- Publication type:
- Article
Manual vs automated <sup>68</sup>Ga‐radiolabelling—A comparison of optimized processes.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2020, v. 63, n. 4, p. 162, doi. 10.1002/jlcr.3821
- By:
- Publication type:
- Article
Biodistribution and post-therapy dosimetric analysis of [<sup>177</sup>Lu]Lu-DOTA<sup>ZOL</sup> in patients with osteoblastic metastases: first results.
- Published in:
- EJNMMI Research, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1186/s13550-019-0566-x
- By:
- Publication type:
- Article
Ethanol effects on <sup>68</sup>Ga-radiolabelling efficacy and radiolysis in automated synthesis utilizing NaCl post-processing.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2019, v. 4, n. 1, p. N.PAG, doi. 10.1186/s41181-019-0076-1
- By:
- Publication type:
- Article
Preliminary results of biodistribution and dosimetric analysis of [<sup>68</sup>Ga]Ga-DOTA<sup>ZOL</sup>: a new zoledronate-based bisphosphonate for PET/CT diagnosis of bone diseases.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Outcome and safety of rechallenge [<sup>177</sup>Lu]Lu-PSMA-617 in patients with metastatic prostate cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 5, p. 1073, doi. 10.1007/s00259-018-4222-x
- By:
- Publication type:
- Article
Theranostics in nuclear medicine practice.
- Published in:
- OncoTargets & Therapy, 2017, v. 10, p. 4821, doi. 10.2147/OTT.S140671
- By:
- Publication type:
- Article
Overall survival and response pattern of castration-resistant metastatic prostate cancer to multiple cycles of radioligand therapy using [Lu]Lu-PSMA-617.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2017, v. 44, n. 9, p. 1448, doi. 10.1007/s00259-017-3716-2
- By:
- Publication type:
- Article
The impact of repeated cycles of radioligand therapy using [Lu]Lu-PSMA-617 on renal function in patients with hormone refractory metastatic prostate cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2017, v. 44, n. 9, p. 1473, doi. 10.1007/s00259-017-3681-9
- By:
- Publication type:
- Article
<sup>68</sup>Ga-PSMA-11 PET as a Gatekeeper for the Treatment of Metastatic Prostate Cancer with<sup>223</sup>Ra: Proof of Concept.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, n. 3, p. 438, doi. 10.2967/jnumed.116.178533
- By:
- Publication type:
- Article
Predictors of Response to Radioligand Therapy of Metastatic Castrate-Resistant Prostate Cancer with <sup>177</sup>Lu-PSMA-617.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, n. 2, p. 312, doi. 10.2967/jnumed.116.178228
- By:
- Publication type:
- Article
Early side effects and first results of radioligand therapy with Lu-DKFZ-617 PSMA of castrate-resistant metastatic prostate cancer: a two-centre study.
- Published in:
- EJNMMI Research, 2015, v. 5, n. 1, p. 1, doi. 10.1186/s13550-015-0114-2
- By:
- Publication type:
- Article